Watson Pharmaceuticals Invests in $15M New Jersey Expansion
05/27/2010
"Over the past year, we have outgrown our current administrative headquarters site, as our U.S. and global business has rapidly grown," said Paul Biscaro, Watson president and CEO. "This new facility will ensure that we have a single location for the leadership and shared services functions that are driving our global growth."
New Jersey's Business Employment Incentive Program (BEIP) has extended Watson a grant of approximately $7.3 million over the next 10 years from the state's Economic Development Authority. It has also been approved for a $290,000 Business Retention and Relocation Assistance Grant (BRRAG) to retain 200 jobs in New Jersey.
Watson was the country's third largest producer of generic drugs in 2009 based on prescriptions dispensed. It specializes in drugs for urology and women's health.
Project Announcements
Acoustical Sheetmetal Company Expands Virginia Beach, Virginia, Operations
06/17/2025
iCapital To Expand Salt Lake County, Utah, Operations
06/17/2025
ACS Manufacturing Expands Davis County, Utah, Operations
06/17/2025
JetZero Plans Greensboro, North Carolina, Headquarters-Production Operations
06/17/2025
Commercial Specialty Truck Holdings Expands Cynthiana, Kentucky, Operations
06/17/2025
Berner International Expands Shenango Township, Pennsylvania, Manufacturing Operations
06/16/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Navigating the new era of SCIF construction
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Get Your Mega Site ‘Project Ready’
Q2 2025